Variant report

Variant	nsv875731
Chromosome Location	chr2:206346586-206382030
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:206375215-206375434	HepG2	liver:	n/a	n/a
2	ATF2	chr2:206346954-206347775	H1-hESC	embryonic stem cell:	n/a	chr2:206347531-206347545 chr2:206347533-206347544
3	ATF2	chr2:206347117-206347865	H1-hESC	embryonic stem cell:	n/a	chr2:206347531-206347545 chr2:206347533-206347544
4	BCL11A	chr2:206347165-206347444	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr2:206361295-206361315	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr2:206361484-206361926	IMR90	lung:	n/a	n/a
7	CHD2	chr2:206346991-206347849	H1-hESC	embryonic stem cell:	n/a	n/a
8	CREB1	chr2:206347169-206347777	H1-hESC	embryonic stem cell:	n/a	chr2:206347532-206347545
9	CREB1	chr2:206347041-206347841	H1-hESC	embryonic stem cell:	n/a	chr2:206347532-206347545
10	CTBP2	chr2:206346991-206347614	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr2:206361200-206361350	NHDF-neo	bronchial:	n/a	n/a
12	CTCF	chr2:206361256-206361442	IMR90	lung:	n/a	n/a
13	CTCF	chr2:206361220-206361370	AG10803	skin:	n/a	n/a
14	CTCF	chr2:206361220-206361370	AoAF	blood vessel:	n/a	n/a
15	CTCF	chr2:206380660-206380810	HEK293	kidney:	n/a	n/a
16	CTCF	chr2:206361240-206361390	AoAF	blood vessel:	n/a	n/a
17	CTCF	chr2:206364180-206364470	NHDF-neo	bronchial:	n/a	n/a
18	CTCF	chr2:206361260-206361410	AG10803	skin:	n/a	n/a
19	CTCF	chr2:206361260-206361410	HVMF	connective:	n/a	n/a
20	CTCF	chr2:206361280-206361430	AG09319	gingival:	n/a	n/a
21	CTCF	chr2:206361400-206361550	NHDF-neo	bronchial:	n/a	n/a
22	CTCF	chr2:206375600-206375750	AG04449	skin:	n/a	n/a
23	CTCF	chr2:206361320-206361470	HMF	breast:	n/a	n/a
24	CTCF	chr2:206361240-206361390	HMF	breast:	n/a	n/a
25	CTCF	chr2:206361200-206361350	HPF	lung:	n/a	n/a
26	CTCF	chr2:206361200-206361350	NHLF	lung:	n/a	n/a
27	CTCF	chr2:206361320-206361470	BJ	skin:	n/a	n/a
28	CTCF	chr2:206361260-206361410	AG04450	lung:	n/a	n/a
29	CTCF	chr2:206361300-206361450	HFF	foreskin:	n/a	n/a
30	CTCF	chr2:206361240-206361390	HEK293	kidney:	n/a	n/a
31	CTCF	chr2:206361280-206361430	HPAF	blood vessel:	n/a	n/a
32	CTCF	chr2:206375680-206375830	AG04449	skin:	n/a	n/a
33	CTCF	chr2:206361520-206361670	AG09319	gingival:	n/a	n/a
34	CTCF	chr2:206361240-206361390	HA-sp	spinal cord:	n/a	n/a
35	CTCF	chr2:206361200-206361350	HPAF	blood vessel:	n/a	n/a
36	CTCF	chr2:206361220-206361370	SK-N-SH_RA	brain:	n/a	n/a
37	EGR1	chr2:206347097-206347518	H1-hESC	embryonic stem cell:	n/a	chr2:206347231-206347244 chr2:206347230-206347245 chr2:206347231-206347244 chr2:206347233-206347243
38	EP300	chr2:206346950-206347666	H1-hESC	embryonic stem cell:	n/a	chr2:206347192-206347206 chr2:206347005-206347019 chr2:206347611-206347625 chr2:206347194-206347208
39	EP300	chr2:206375001-206375453	HepG2	liver:	n/a	n/a
40	GATA3	chr2:206361312-206361926	SK-N-SH	brain:	n/a	n/a
41	GTF2F1	chr2:206347171-206347313	H1-hESC	embryonic stem cell:	n/a	n/a
42	HDAC2	chr2:206347024-206347518	H1-hESC	embryonic stem cell:	n/a	n/a
43	HNF4A	chr2:206375134-206375440	HepG2	liver:	n/a	chr2:206375245-206375257 chr2:206375243-206375258 chr2:206375243-206375258 chr2:206375245-206375257 chr2:206375244-206375258 chr2:206375244-206375258 chr2:206375245-206375257 chr2:206375244-206375257 chr2:206375244-206375259 chr2:206375244-206375259 chr2:206375245-206375258 chr2:206375244-206375258 chr2:206375242-206375260
44	JUN	chr2:206359387-206359517	H1-hESC	embryonic stem cell:	n/a	n/a
45	JUND	chr2:206360592-206360916	H1-hESC	embryonic stem cell:	n/a	n/a
46	JUND	chr2:206347104-206347776	H1-hESC	embryonic stem cell:	n/a	chr2:206347534-206347543
47	KAP1	chr2:206361649-206361826	HEK293	kidney:	n/a	n/a
48	MAFK	chr2:206377316-206377369	HepG2	liver:	n/a	chr2:206377323-206377334 chr2:206377321-206377335 chr2:206377322-206377333 chr2:206377322-206377333 chr2:206377323-206377334 chr2:206377318-206377333
49	MAX	chr2:206347072-206347927	H1-hESC	embryonic stem cell:	n/a	n/a
50	MAX	chr2:206363494-206363675	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:206349064-206349114	K562	blood:	n/a
2	chr2:206349064-206349114	K562	blood:	n/a
3	chr2:206360335-206360385	CMK	blood:	n/a
4	chr2:206349064-206349114	PrEC	prostate:	n/a
5	chr2:206349708-206349758	HIPEpiC	eye:	n/a
6	chr2:206349064-206349114	GM12892	blood:	n/a
7	chr2:206347777-206347827	PFSK-1	brain:	n/a
8	chr2:206360335-206360385	HEK293	kidney:	embryo
9	chr2:206349708-206349758	SK-N-SH	brain:	n/a
10	chr2:206360335-206360385	ECC-1	luminal epithelium:	n/a
11	chr2:206347777-206347827	T-47D	breast:	n/a
12	chr2:206347777-206347827	U87	brain:	n/a
13	chr2:206349708-206349758	BE2_C	brain:	n/a
14	chr2:206375718-206375768	Hepatocyte	liver:	n/a
15	chr2:206349064-206349114	SK-N-SH	brain:	n/a
16	chr2:206347777-206347827	K562	blood:	n/a
17	chr2:206349064-206349114	HRPEpiC	eye:	n/a
18	chr2:206347777-206347827	Caco-2	colon:	n/a
19	chr2:206375718-206375768	K562	blood:	n/a
20	chr2:206375718-206375768	RPTEC	kidney:	n/a
21	chr2:206349064-206349114	NHDF-neo	bronchial:	n/a
22	chr2:206347777-206347827	NT2-D1	testis:	n/a
23	chr2:206349064-206349114	HIPEpiC	eye:	n/a
24	chr2:206375718-206375768	AG04449	skin:	fetal
25	chr2:206375718-206375768	HCM	heart:	n/a
26	chr2:206349708-206349758	PFSK-1	brain:	n/a
27	chr2:206349708-206349758	SK-N-MC	brain:	n/a
28	chr2:206360335-206360385	IMR90	lung:	fetal
29	chr2:206349064-206349114	AG04450	lung:	fetal
30	chr2:206375718-206375768	BJ	skin:	n/a
31	chr2:206349064-206349114	HCM	heart:	n/a
32	chr2:206347777-206347827	A549	lung:	n/a
33	chr2:206360335-206360385	Jurkat	blood:	n/a
34	chr2:206375718-206375768	H1-hESC	embryonic stem cell:	embryo
35	chr2:206349064-206349114	HCF	heart:	n/a
36	chr2:206349064-206349114	HNPCEpiC	eye:	n/a
37	chr2:206347777-206347827	HRCEpiC	kidney:	n/a
38	chr2:206349064-206349114	AoSMC	blood vessel:	n/a
39	chr2:206360335-206360385	SK-N-SH	brain:	n/a
40	chr2:206349064-206349114	NH-A	brain:	n/a
41	chr2:206349064-206349114	PANC-1	pancreas:	n/a
42	chr2:206360335-206360385	MCF10A-Er-Src	breast:	n/a
43	chr2:206349708-206349758	NHBE	bronchial:	n/a
44	chr2:206349064-206349114	T-47D	breast:	n/a
45	chr2:206349064-206349114	HL-60	blood:	n/a
46	chr2:206349708-206349758	HRCEpiC	kidney:	n/a
47	chr2:206347777-206347827	GM19239	blood:	n/a
48	chr2:206347777-206347827	HepG2	liver:	n/a
49	chr2:206360335-206360385	NHDF-neo	bronchial:	n/a
50	chr2:206375718-206375768	GM12878	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:206359433..206361731-chr2:206363684..206366442,2	MCF-7	breast:
2	chr2:206359433..206361731-chr2:206363684..206366442,2	MCF-7	breast:
3	chr2:206358113..206360299-chr6:27112418..27114699,2	MCF-7	breast:
4	chr2:206341022..206343808-chr2:206347982..206349930,2	K562	blood:

Variant related genes	Relation type
PARD3B	TF binding region
PARD3B	CpG island
ENSG00000197903	chromatin interactions

Extended variants
information (count: 1241 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:1241 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6760832	chr2:206346586-206346587	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs10172495	chr2:206346590-206346591	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs544413613	chr2:206346673-206346674	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs117362327	chr2:206346684-206346685	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs556072238	chr2:206346719-206346720	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs547619826	chr2:206346728-206346729	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs73058133	chr2:206346789-206346790	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs565728314	chr2:206346790-206346791	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs142321974	chr2:206346799-206346800	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs188145918	chr2:206346803-206346804	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs569741879	chr2:206346902-206346903	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs537059235	chr2:206346935-206346936	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs4377318	chr2:206346955-206346956	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs112525294	chr2:206346971-206346972	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs555361204	chr2:206347031-206347032	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs374618044	chr2:206347039-206347040	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs538476233	chr2:206347043-206347044	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs568738924	chr2:206347045-206347046	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs1877343	chr2:206347122-206347123	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs554382709	chr2:206347125-206347126	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs56985678	chr2:206347152-206347153	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs572529866	chr2:206347159-206347160	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs115499228	chr2:206347160-206347161	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs557851273	chr2:206347170-206347171	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs369547652	chr2:206347191-206347192	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs543417692	chr2:206347231-206347232	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs374212834	chr2:206347334-206347335	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs573921553	chr2:206347357-206347358	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs6735804	chr2:206347359-206347360	Enhancers Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs551184277	chr2:206347384-206347385	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs533002845	chr2:206347404-206347405	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs551568954	chr2:206347415-206347416	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs1877342	chr2:206347416-206347417	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs7559015	chr2:206347457-206347458	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs373298478	chr2:206347475-206347476	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs549045978	chr2:206347480-206347481	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs376460070	chr2:206347499-206347500	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs567138596	chr2:206347505-206347506	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs144622587	chr2:206347508-206347509	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs547749480	chr2:206347527-206347528	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs542140448	chr2:206347539-206347540	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs181217256	chr2:206347549-206347550	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs1877341	chr2:206347568-206347569	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs566524323	chr2:206347625-206347626	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs557886182	chr2:206347646-206347647	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs576178585	chr2:206347695-206347696	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs537141267	chr2:206347807-206347808	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs6739203	chr2:206347822-206347823	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs184726954	chr2:206347825-206347826	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs541388696	chr2:206347828-206347829	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Cervical cancer	21062161	CNVD
Intracranial aneurysm	16715129	CNVD
Hepatocellular carcinoma	16750200	CNVD
Prostate cancer	16573809	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Glioblastoma multiforme	22286061	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Non-small cell lung cancer	21829676	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:289 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:206340800-206347000	Weak transcription	Fetal Stomach	stomach
2	chr2:206341000-206346600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr2:206341400-206347000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr2:206342600-206348600	Weak transcription	Fetal Heart	heart
5	chr2:206342800-206347400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
6	chr2:206342800-206347400	Weak transcription	HSMMtube	muscle
7	chr2:206342800-206347800	Weak transcription	Muscle Satellite Cultured Cells	--
8	chr2:206343000-206347000	Weak transcription	HSMM	muscle
9	chr2:206343000-206347600	Weak transcription	Ovary	ovary
10	chr2:206343600-206347600	Weak transcription	Fetal Lung	lung
11	chr2:206345400-206348000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr2:206345600-206350400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
13	chr2:206345800-206347200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr2:206346000-206346800	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr2:206346000-206349800	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr2:206346000-206349800	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr2:206346000-206350000	Enhancers	H1 Cell Line	embryonic stem cell
18	chr2:206346200-206347000	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr2:206346200-206347400	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr2:206346200-206350000	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr2:206346200-206365200	Weak transcription	Aorta	Aorta
22	chr2:206346400-206347000	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr2:206346400-206348000	Enhancers	H9 Cell Line	embryonic stem cell
24	chr2:206346600-206347800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:206346600-206349600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr2:206346800-206347200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
27	chr2:206346800-206349400	Enhancers	Brain Germinal Matrix	brain
28	chr2:206346800-206350200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
29	chr2:206347000-206347200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
30	chr2:206347000-206347200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
31	chr2:206347000-206347800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr2:206347000-206348200	Enhancers	HSMM	muscle
33	chr2:206347000-206350200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr2:206347000-206350200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr2:206347000-206350600	Enhancers	Fetal Muscle Leg	muscle
36	chr2:206347000-206350800	Enhancers	Fetal Stomach	stomach
37	chr2:206347200-206347400	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr2:206347200-206347400	Enhancers	Brain Anterior Caudate	brain
39	chr2:206347200-206347600	Active TSS	HUES48 Cell Line	embryonic stem cell
40	chr2:206347200-206347600	Active TSS	HUES64 Cell Line	embryonic stem cell
41	chr2:206347200-206347600	Enhancers	Fetal Muscle Trunk	muscle
42	chr2:206347200-206347800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
43	chr2:206347200-206348200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr2:206347200-206349600	Enhancers	Fetal Brain Male	brain
45	chr2:206347400-206347800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr2:206347400-206347800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
47	chr2:206347400-206348000	Enhancers	Fetal Kidney	kidney
48	chr2:206347400-206348200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
49	chr2:206347400-206348400	Enhancers	HSMMtube	muscle
50	chr2:206347400-206348600	Weak transcription	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links